ZITUVIMET Trademark

Trademark Overview

On Wednesday, November 23, 2022, a trademark application was filed for ZITUVIMET with the United States Patent and Trademark Office. The USPTO has given the ZITUVIMET trademark a serial number of 97690293. The federal status of this trademark filing is THIRD EXTENSION - GRANTED as of Sunday, February 2, 2025. This trademark is owned by Zydus Pharmaceuticals (USA) Inc.. The ZITUVIMET trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for treating diabetes
zituvimet

General Information

Serial Number97690293
Word MarkZITUVIMET
Filing DateWednesday, November 23, 2022
Status732 - THIRD EXTENSION - GRANTED
Status DateSunday, February 2, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, April 4, 2023

Trademark Statements

Goods and ServicesPharmaceutical preparations for treating diabetes

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, November 28, 2022
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameZydus Pharmaceuticals (USA) Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressPennington, NJ 08534
Party NameZydus Pharmaceuticals (USA) Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressPennington, NJ 08534

Trademark Events

Event DateEvent Description
Monday, November 28, 2022NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Saturday, November 26, 2022NEW APPLICATION ENTERED
Wednesday, February 15, 2023ASSIGNED TO EXAMINER
Friday, February 24, 2023APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, March 15, 2023NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, April 4, 2023PUBLISHED FOR OPPOSITION
Tuesday, April 4, 2023OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, May 30, 2023NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Thursday, October 26, 2023SOU TEAS EXTENSION RECEIVED
Thursday, October 26, 2023SOU EXTENSION 1 FILED
Thursday, October 26, 2023SOU EXTENSION 1 GRANTED
Saturday, October 28, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, January 3, 2024TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, January 3, 2024ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, January 3, 2024TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, January 3, 2024TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Tuesday, April 16, 2024SOU TEAS EXTENSION RECEIVED
Tuesday, April 16, 2024SOU EXTENSION 2 FILED
Tuesday, April 16, 2024SOU EXTENSION 2 GRANTED
Wednesday, April 17, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, November 18, 2024SOU EXTENSION 3 FILED
Monday, November 18, 2024SOU TEAS EXTENSION RECEIVED
Sunday, February 2, 2025SOU EXTENSION 3 GRANTED
Sunday, February 2, 2025CASE ASSIGNED TO INTENT TO USE PARALEGAL
Monday, February 3, 2025NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

Related Keywords

zituvimet diabetes treating preparations pharmaceutical